Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (141-150 of 253) with videos related to

Pageof 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphomaA M Evens, K R Carson, J Kolesar, et al.
British Journal of Haematology|April 23, 2010
Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanismsSavita Bhalla, Leo I Gordon, Kevin David, et al.
Cancer Research|March 19, 2016
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin LymphomaDashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, et al.
BMC Cancer|July 14, 2023
Factors associated with health-related quality of life in a cohort of cancer survivors in New JerseySharon Manne, Katie Devine, Shawna Hudson, et al.
Journal of Cancer Survivorship : Research and Practice|July 29, 2022
COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivorsAdana A M Llanos, Angela J Fong, Nabarun Ghosh, et al.
Journal of Cancer Survivorship : Research and Practice|December 10, 2024
Household income and county income inequality are associated with financial hardship among cancer survivors in New JerseyIrina B Grafova, Katie A Devine, Shawna V Hudson, et al.
British Journal of Haematology|November 17, 2011
Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeChadi Nabhan, Sonali M Smith, Irene Helenowski, et al.
British Journal of Haematology|December 29, 2007
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphomaAndrew M Evens, Jane N Winter, Nanjiang Hou, et al.
Bone Marrow Transplantation|June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?J Mehta, L I Gordon, M S Tallman, et al.
Pageof 26

Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphomaA M Evens, K R Carson, J Kolesar, et al.
British Journal of Haematology|April 23, 2010
Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanismsSavita Bhalla, Leo I Gordon, Kevin David, et al.
Cancer Research|March 19, 2016
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin LymphomaDashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, et al.
BMC Cancer|July 14, 2023
Factors associated with health-related quality of life in a cohort of cancer survivors in New JerseySharon Manne, Katie Devine, Shawna Hudson, et al.
Journal of Cancer Survivorship : Research and Practice|July 29, 2022
COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivorsAdana A M Llanos, Angela J Fong, Nabarun Ghosh, et al.
Journal of Cancer Survivorship : Research and Practice|December 10, 2024
Household income and county income inequality are associated with financial hardship among cancer survivors in New JerseyIrina B Grafova, Katie A Devine, Shawna V Hudson, et al.
British Journal of Haematology|November 17, 2011
Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeChadi Nabhan, Sonali M Smith, Irene Helenowski, et al.
British Journal of Haematology|December 29, 2007
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphomaAndrew M Evens, Jane N Winter, Nanjiang Hou, et al.
Bone Marrow Transplantation|June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?J Mehta, L I Gordon, M S Tallman, et al.
Pageof 26